Literature DB >> 20152299

Delusional versus nondelusional body dysmorphic disorder.

Serafino G Mancuso1, Natalie P Knoesen, David J Castle.   

Abstract

This study assessed demographic and clinical features in 65 subjects with body dysmorphic disorder (BDD) and compared the 39 (60%) with the delusional form (receiving an additional diagnosis of delusional disorder, somatic type) with those who did not meet delusionality criteria. Delusional and nondelusional patients did not statistically differ on most demographic and clinical variables. Delusional patients, however, had significantly more severe BDD symptoms at both baseline and follow-up assessments than those of nondelusional patients. Furthermore, poorer insight was significantly associated with more severe BDD symptoms at both baseline and follow-up. Overall improvement in BDD symptom severity was similar for the 2 groups. Our results support other studies in the view that BDD and its delusional variant have more similarities than differences and that the delusional variant may be simply a more severe form of BDD. Implications for the diagnostic classification of BDD and future research directions are discussed. Crown Copyright 2010. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20152299     DOI: 10.1016/j.comppsych.2009.05.001

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  21 in total

Review 1.  Olfactory reference syndrome: issues for DSM-V.

Authors:  Jamie D Feusner; Katharine A Phillips; Dan J Stein
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

Review 2.  Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?

Authors:  Katharine A Phillips; Dan J Stein; Scott L Rauch; Eric Hollander; Brian A Fallon; Arthur Barsky; Naomi Fineberg; David Mataix-Cols; Ygor Arzeno Ferrão; Sanjaya Saxena; Sabine Wilhelm; Megan M Kelly; Lee Anna Clark; Anthony Pinto; O Joseph Bienvenu; Joanne Farrow; James Leckman
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

Review 3.  Body dysmorphic disorder: some key issues for DSM-V.

Authors:  Katharine A Phillips; Sabine Wilhelm; Lorrin M Koran; Elizabeth R Didie; Brian A Fallon; Jamie Feusner; Dan J Stein
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

Review 4.  Visual processing in anorexia nervosa and body dysmorphic disorder: similarities, differences, and future research directions.

Authors:  Sarah K Madsen; Cara Bohon; Jamie D Feusner
Journal:  J Psychiatr Res       Date:  2013-06-27       Impact factor: 4.791

Review 5.  Delusional versus nondelusional body dysmorphic disorder: recommendations for DSM-5.

Authors:  Katharine A Phillips; Ashley S Hart; Helen Blair Simpson; Dan J Stein
Journal:  CNS Spectr       Date:  2013-05-10       Impact factor: 3.790

6.  A comparison of insight in body dysmorphic disorder and obsessive-compulsive disorder.

Authors:  Katharine A Phillips; Anthony Pinto; Ashley S Hart; Meredith E Coles; Jane L Eisen; William Menard; Steven A Rasmussen
Journal:  J Psychiatr Res       Date:  2012-07-21       Impact factor: 4.791

7.  Inverted face processing in body dysmorphic disorder.

Authors:  Jamie D Feusner; Hayley Moller; Lily Altstein; Catherine Sugar; Susan Bookheimer; Joanne Yoon; Emily Hembacher
Journal:  J Psychiatr Res       Date:  2010-11       Impact factor: 4.791

8.  The power within: The experimental manipulation of power interacts with trait BDD symptoms to predict interoceptive accuracy.

Authors:  Jonathan W Kunstman; Elise M Clerkin; Kateyln Palmer; M Taylar Peters; Dorian R Dodd; April R Smith
Journal:  J Behav Ther Exp Psychiatry       Date:  2015-08-10

Review 9.  Cognitive-behavioral therapy for youth with body dysmorphic disorder: current status and future directions.

Authors:  Katharine A Phillips; Jamison Rogers
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2011-04

10.  Abnormal brain network organization in body dysmorphic disorder.

Authors:  Donatello Arienzo; Alex Leow; Jesse A Brown; Liang Zhan; Johnson Gadelkarim; Sarit Hovav; Jamie D Feusner
Journal:  Neuropsychopharmacology       Date:  2013-01-15       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.